Safety and effectiveness of disease-modifying therapies after switching from natalizumab. - Zeineddine M; Al-Roughani R; Farouk Ahmed S; Khoury S; El-Ayoubi N; Al-Mahdawi A; Al-Khabouri J; Al-Asmi A; Chentouf A; Inshasi J; Gouider R; Mrabet S; et al. (Multiple sclerosis (Houndmills, Basingstoke, England), 2024)